86 results
Page 2 of 5
F-3
udmb 7m9ph
17 Feb 22
Shelf registration (foreign)
4:14pm
F-3
t3mq3m
17 Feb 22
Shelf registration (foreign)
4:14pm
F-3
EX-5.1
a8vaythk3 sqij8
17 Feb 22
Shelf registration (foreign)
4:14pm
6-K
EX-99.3
3q02w qh4c934i5u
28 Jan 22
ObsEva Announces Corporate Updates
5:16pm
424B7
k2w1k2d619n vbzukc
23 Nov 21
Prospectus with selling stockholder info
4:06pm
F-3
EX-5.1
6gn68m19unqjy143 zz
10 Nov 21
Shelf registration (foreign)
5:23pm
F-3
drc4qw3nva0lje7 k2cz
10 Nov 21
Shelf registration (foreign)
5:23pm
6-K/A
EX-99.2
knzhh 0uytx08sd47
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
6-K/A
EX-99.5
sbcg68uk
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
6-K/A
EX-99.1
by2c5
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
6-K
EX-99.2
7s11bulyt07u43544u
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
6-K
EX-99.5
g61wpx f0q
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
6-K
EX-99.1
3ijcw fr3
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
6-K
EX-99.1
9u0x1lyx2q6y
22 Apr 21
ObsEva Annual General Meeting 2021
6:31am
6-K
EX-5.1
uuowzoo52iil
5 Mar 21
Current report (foreign)
8:15am
6-K
EX-1.1
9nbk6b4f 099
5 Mar 21
Current report (foreign)
8:15am
424B5
4744 cfvh3ftwblj6h
5 Mar 21
Prospectus supplement for primary offering
7:55am